C
Christof Vulsteke
Researcher at University of Antwerp
Publications - 7
Citations - 106
Christof Vulsteke is an academic researcher from University of Antwerp. The author has contributed to research in topics: Cancer & Disease. The author has an hindex of 4, co-authored 7 publications receiving 62 citations.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 and cancer: Are they really partners in crime?
Peter A. van Dam,Manon T. Huizing,Gino Mestach,Stazie Dierckxsens,Wiebren A.A. Tjalma,Xuan Bich Trinh,K. Papadimitriou,Sevilay Altintas,Jan B. Vermorken,Christof Vulsteke,Annelies Janssens,Zwi N. Berneman,Hans Prenen,Leander Meuris,Wim Vanden Berghe,Evelien Smits,Marc Peeters +16 more
TL;DR: Underlying immunosuppression, elevated cytokine levels, altered expression of the angiotensin converting enzyme and TMPRSS2, and a prothrombotic status may fuel the effects of a SARS-CoV-2 in some cancer patients, but have the potential to be used as biomarkers for severe disease and therapeutic targets.
Journal ArticleDOI
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.
Hannelore Denys,Corina L Martinez-Mena,Marc T Martens,Randal G D'Hondt,Marie-Pascale L Graas,Ella Evron,Georgeta Fried,Noa Ben-Baruch,Christof Vulsteke,Mona M Van Steenberghe +9 more
TL;DR: The results of the BELIS study support that trastuzumab SC can be safely administered at home by a HCP and all patients considered this setting as beneficial.
Journal ArticleDOI
AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients
Marika Rasschaert,Christof Vulsteke,Sven De Keersmaeker,Kathleen Vandenborne,Stefanie Dias,Vincent Verschaeve,Peter Vuylsteke,Ilse Van Brussel,Jo Ravelingien,Peter van Dam,Eva Segelov,Marc Peeters +11 more
TL;DR: The application of an interactive PRO-system in routine symptom management of cancer patients allowed standardized documentation of toxicities and recorded a high compliance with oral treatment.
Journal ArticleDOI
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform.
Marc Peeters,Peter van Dam,Marika Rasschaert,Christof Vulsteke,Sven De Keersmaecker,Lieselot Croes,Ilse Van Brussel,Jo Ravelingien,Annelies Janssens,Hans Prenen +9 more
TL;DR: One of the strategies to treat patients with cancer as safe as possible is to reduce hospital visits to a strict minimum, and this work has previously reported on AMTRA.
Journal ArticleDOI
Blood cytokine analysis suggests that sars‐cov‐2 infection results in a sustained tumour promoting environment in cancer patients
Fien H. R. De Winter,An Hotterbeekx,Manon T. Huizing,Angelina Konnova,Erik Fransen,Bart ‘s Jongers,Ravi Kumar Jairam,Vincent Van averbeke,Pieter Moons,Ella Roelant,Debbie Le Blon,Wim Vanden Berghe,Annelies Janssens,Willem Lybaert,Lieselot Croes,Christof Vulsteke,Surbhi Malhotra-Kumar,Herman Goossens,Zwi N. Berneman,Marc Peeters,Peter van Dam,Samir Kumar-Singh +21 more
TL;DR: In this article, the authors investigated how SARS-CoV-2 infection impacts the already altered CCG levels in solid or haematological malignancies, specifically, whether there is a protective effect or rather a potentially higher risk for major COVID-19 complications in cancer patients due to elevated CCGs linked to cancer progression.